Route of delivery and baseline left ventricular ejection fraction, key factors of bone-marrow-derived cell therapy for ischaemic heart disease

Published year

2009

Authors

Brunskill S, Hyde CJ, Doree C,, Watt SM, Martin-Rendon E

Abstract

PubMed

Full text (subscription may be required)

Wiley

Additional Information

European Journal of Heart Failure 2009; 11(9): 887-96.